Key result
Surrogate insulin sensitivity indices correlate with clamp measures overall, but fail in IFG or IFG/IGT.
Cross-Sectional (n=467)
Answers are grounded in this paper and cite their sources.
OBJECTIVE: The goal of this study was to evaluate the performance of surrogate measures of insulin sensitivity and insulin secretion. RESEARCH DESIGN AND METHODS: The homeostasis model assessment (HOMA) of insulin resistance (IR) and the insulin sensitivity index (S(i)) from oral glucose tolerance test (OGTT) were compared with the M value from a hyperinsulinemic-euglycemic clamp in 467 subjects with various degrees of glucose tolerance. Endogenous glucose production (EGP) and hepatic insulin sensitivity were determined in a subset (n = 143). Insulin secretion was estimated as the HOMA beta-cell index and as the insulinogenic index from the first 30 min of the OGTT (I/G30) and compared with the first-phase insulin response (FPIR) to an intravenous glucose tolerance test (n = 218). RESULTS: The M value correlated with the HOMA-IR (r = -0.591, P < 0.0001) and the S(i) (r = 0.533, P < 0.0001) indexes in the total study group. HOMA-IR correlated with basal EGP in the total study group (r = 0.378, P < 0.0005) and in subjects with diabetes (r = 0.330, P = 0.01). However, neither HOMA-IR nor S(i) correlated significantly with the M value in subjects with impaired fasting glucose (IFG) (r = -0.108, P = 0.5; r = 0.01, P = 0.9) or IFG/impaired glucose tolerance (IGT) (r = -0.167, P = 0.4; r = 0.09, P = 0.6). The HOMA-IR correlated with hepatic insulin sensitivity in the whole study group (r = -0.395, P < 0.005) as well as in the IFG/IGT subgroup (r = -0.634, P = 0.002) and in the diabetic subgroup (r = -0.348, P = 0.008). In subjects with IFG/IGT, hepatic insulin sensitivity was the most important determinant of HOMA-IR, explaining 40% of its variation. The HOMA beta-cell index showed a weak correlation with FPIR in the whole study group (r = 0.294, P = 0.001) but not in the subgroups. In contrast, the I/G30 correlated with FPIR in the whole study group (r = 0.472, P < 0.0005) and in the IFG/IGT subgroup (r = 0.493, P < 0.005). CONCLUSIONS: HOMA-IR is dependent upon both peripheral and hepatic insulin sensitivity, the contribution of which differs between subjects with normal and elevated fasting glucose concentrations. These discrepancies develop as a consequence of a nonparallel deterioration of the variables included in the equations with worsening of glucose tolerance.
No takes yet. Share an insight, caveat, or question.
Tripathy et al. (2004) conducted a cross-sectional in Various degrees of glucose tolerance (including normal glucose tolerance, impaired fasting glucose, impaired glucose tolerance, and diabetes) (n=467). Surrogate measures of insulin sensitivity and secretion (HOMA-IR, OGTT insulin sensitivity index, HOMA beta-cell index, insulinogenic index) vs. Hyperinsulinemic-euglycemic clamp M value, basal endogenous glucose production, hepatic insulin sensitivity, and intravenous glucose tolerance test first-phase insulin response was evaluated on Correlation of HOMA-IR and OGTT insulin sensitivity index with clamp M value (r = -0.591 (HOMA-IR); r = 0.533 (Si), p=<0.0001). HOMA-IR and OGTT insulin sensitivity index correlated with clamp M value overall, but not in subjects with IFG or IFG/IGT.
Synapse has enriched 10 related papers. Consider them for comparative context: